Overall rank by patents
#20,131
of 50,000 tracked assignees
USPTO PatentsView assignee record - 14 granted patents across 11 technology areas, recorded in grant years 2020–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A23K (FODDER).
The verdict
According to USPTO PatentsView, Native ranks #20,131 of 50,000 tracked US assignees by granted-patent volume, with 14 patents across 11 technology areas.
USPTO PatentsView assignee plate
Corpus R20131 · US Corporation #20,131 · 14 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH
Nearest grant-volume peer: Nalpropion Pharmaceuticals Llc (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Native Microbials · this assignee
43 score
3D Lighting Innovati… · lowest
7 score
What this shows Native Microbials, Inc. stamps GRANTS-MICRO, MID-PACK, PHOTO-FINISH, CPC-FOCUS, INNOV-PAR, CLAIMS-DENSE, TYPE-USCORP, SPAN-YRS, BOOK-RICH. Volume places it #20,131 of 50,000; Innovation Score 43.4/100 sits in the top 28% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is Nalpropion Pharmaceuticals Llc (±0 grants).
Native Microbials, Inc. has been granted 14 US utility patents between 2020 and 2024, placing Native Microbials, Inc. at #20,131 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 11 distinct Cooperative Patent Classification (CPC) subclasses, averaging 22.4 claims per patent with primary concentration in A23K (FODDER). As a US Corporation, Native Microbials, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Native sits between Nalpropion Pharmaceuticals Llc (14 patents, rank #20,153) and New Power Concepts Llc (14 patents, rank #20,161) - the closest US assignees by grant volume. The composite Innovation Score of 43.4/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Grant cadence records the difference between two grant-year windows. Historical data spans 2020 through 2024, with 14 total grants over that period. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The US Corporation classification provides context for the assignee record, not a conclusion about its business strategy.
Claim depth and technology breadth describe this aggregate record. Native Microbials, Inc.'s 22.4 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 11 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Nalpropion Pharmaceuticals LLC
14 patents
Nanjing Horizon Robotics Technology Co., Ltd.
14 patents
Nanostar, Inc.
14 patents
National Diversified Sales, Inc.
14 patents
Neander Motors AG
14 patents
NeuraLight Ltd.
14 patents
Neurasignal, Inc.
14 patents
New Power Concepts LLC
14 patents
Native Microbials, Inc.
14 patents
What this shows Native holds 14 patents at rank #20,157, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #20,157 in granted patent volume.
Other assignees with the most granted patents in Native's primary technology class.
Native's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
43 Top 28% higher than 72% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 3 | 21.4% |
| 2021 | 3 | 21.4% |
| 2022 | 1 | 7.1% |
| 2023 | 1 | 7.1% |
| 2024 | 6 | 42.9% |
Top 11 of 11 technology areas
Overall rank by patents
#20,131
of 50,000 tracked assignees
43.4 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.